Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 30, 2000 - Issue 4
75
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Preparation of Benz[b]Indeno[1,2-e]Pyran-11(6H)-Ones and Benz[b]Indeno[1,2-e]Thiopyran-11(6H)-One from Dilithiated 2-Indanone and Lithiated Methyl Salicylates or Lithiated Methyl Thiosalicylate

, , , &
Pages 689-699 | Received 01 Jul 1999, Published online: 04 Dec 2007

References

  • Hepworth , J. D. 1984 . “ Pyrans and Fused Pyrans: (iii) Synthesis and Applications ” . In Comprehensive Heterocyclic Chemistry , Edited by: Katritzky , A. R. and Rees , C. W. Vol. 3 , 816 – 830 . New York, New York : Pergamon Press . Part 2B, b, Wawzonek, S. in “Heterocyclic Compounds,” Vol. 2, Elderfield, R. C., Eds., John Wiley and Sons, Inc., New York, New York, 1951, pp. 173. c. Livingstone, R. in “Rodd's Chemistry of Carbon Compounds,” Vol. IV, Part E., Coffey, S., Eds., Elsevier, Amsterdam, 1971, d, Ellis, G. P., Chem. Heterocycl. Compd. 1977, 31, 738 and 816.
  • Goertlitzer , K. 1975 . Arch. Pharm. (Weinheim Ger.) , 308 : 81 Indeno-flavone 1: Benz[b]indeno[2,1-e]pyran-10(11H)-ones, See:
  • Goertlitzer , K. 1975 . Arch. Pharm. (Weinheim Ger.) , 308 : 272 Indeno-thioflavone 2: Benz[b]indeno[2,1-e]thiopyran-10(11H)-one, See also
  • Boyd , G. V. , Hewson , D. and Newberry , R. A. 1969 . J. Chem. Soc. , C : 935 Indeno-chromone 3: Benz[b]indeno[1,2-e]pyran-11(6H)-ones, See: a b. Boyd, G. V., and Hewson, D., Chem. Commun. 1969, 935.
  • Indeno-thiochromone 10: Benz[b]indeno-[1,2-e]thiopyran-11(6H)-one, new and prepared during this investigation.
  • Lambert , J. B. and Wharry , S. M. 1978 . J. Chem. Soc., Chem. Commun. , : 172 b, Lambert, J. B., and Wharry, S. M., J. Am. Chem. Soc. 1982, 104, 5857.
  • Baierweck , P. , Hoell , D. and Muellen , K. 1985 . Angew. Chem. , 97 : 959
  • Livingston , M. J. , Chick , M. F. , Shealy , E. O. , Park , D. J. , Fulmer , T. D. and Beam , C. F. 1982 . J. Heterocycl. Chem. , 19 : 215 b. Hurst, D. R., French, K. L., Angel, A. J., Williams, A. R., Rampey, M. E., Guion, T. S., Chan, K. W., Kassis, C. M., Studer-Martinez, S. L., and Beam, C. F., J. Heterocycl. Chem. 1998, 35, 1357. c. Angel, A. J., Hurst, D. R., Williams, A. R., French, K. L., and Beam, C. F., Synthetic Communications 1998, 28, 1547. d. Davis, S. E., Church, A. C., Tummons, R. C., and Beam, C. F., J. Heterocycl. Chem. 1997, 34, 1159. e. French, K. L., Angel, A. J., Williams, A. R., Hurst, D. R., and Beam, C. F., J. Heterocycl. Chem. 1998, 35, 45.
  • Melting points were obtained with a Mel-Temp II melting point apparatus in open capillary tubes and are uncorrected. b. Combustion analyses for C and H were performed by Quantitative Technologies, Inc., P.O. Box 470, Salem Industrial Park, Bldg. 5, Whitehouse, NJ 08888.
  • Fourier Transform infrared spectra (paraffin oil mulls) were obtained with a Nicolet Impact 410 FT-IR. k Proton and 13C NMR spectra were obtained with a Varian Associates Mercury Oxford 300 MHZ, nuclear magnetic resonance spectrometer, and chemical shifts are recorded in δ ppm downfield from an internal tetramethylsilane (TMS) standard. NMR data: all compounds were soluble in CDCl3: Compd. No.;1H NMR spectra; 13C NMR spectra. 3. 1H NMR: δ 3.94 (s, 2H, CH2), 7.26–7.71, 8.24–8.39 (m, 8H, ArH). 13C NMR: δ 41.1, 122.3, 125.3, 126.8, 127.9, 129.0, 129.4, 130.0, 130.3, 131.7, 137.2, 138.2, 142.4, 160.5, 176.0, and 180.4. 4. 1H NMR: δ 3.93 (s, 3H, ArOCH3), 3.94 (s, 2H, CH2), 6.96–7.05, 7.25–7.47, 8.24–8.30 (m, 7H, ArH). 13C NMR: δ 37.0, 56.1, 100.5, 100.6, 114.3, 118.9, 121.2, 122.9, 123.9, 125.9, 127.7, 134.3, 138.7, 158.3, 163.7, 171.5, and 174.1. 5. 1H NMR: δ 4.04 (s, 2H, CH2), 4.07 (s, 3H, ArOCH3), 7.21–7.50, 7.94–7.97, 8.27–8.29 (m, 6H, ArH). 13C NMR: δ 41.5, 61.0, 118.3, 121.6, 127.2, 128.2, 129.4, 130.4, 132.0, 142.6, 154.4, and 180.2. 6. 1H NMR: δ 3.95 (s, 2H, CH2), 7.24–7.64, 8.22–8.31 (m, 7H, ArH). 13C NMR: δ 41.4, 124.2, 125.7, 127.2, 128.2, 130.0, 130.3, 130.5, 132.0, 135.7, 137.6, 138.4, 142.2, 159.0, 176.4 and 177.3. 7. 1H NMR: δ 3.95 (s, 2H, CH2), 7.26–7.78, 8.21–8.48 (m, 7H, ArH). 13C NMR: δ 37.4, 119.2, 120.5, 121.8, 123.4, 124.3, 127.6, 127.8, 128.1, 129.3, 134.5, 136.4, 138.3, 155.7, 172.4, and 173.2. 8. 1H NMR: δ 3.96 (s, 2H, CH2), 7.26–7.48, 7.92–8.25, and 8.68–8.69 (m, 7H, ArH). 13C NMR: δ 36.8, 89.1, 120.0, 121.2, 122.6, 123.6, 125.7, 126.3, 127.4, 133.8, 134.9, 137.7, 141.3, 155.6, 171.7, and 172.4. 9. 1H NMR: δ 2.45 (s, 3H, ArCH3), 3.88 (s, 2H, CH2), 7.24–7.47, 8.11–8.24 (m, 8H, ArH). 13C NMR: δ 25.3, 41.0, 122.0, 125.0, 126.7, 127.8, 128.6, 129.6, 129.9, 131.6, 138.21, 138.25, 139.3, 142.5, 158.9, 175.8, and 178.4. 10. 1H NMR: δ 4.04 (s, 2H, CH2), 7.26–7.67, 8.55–8.57, 8.71–8.73 (m, 8H, ArH). 13C NMR: δ 41.4, 122.9, 123.1, 125.8, 126.6, 127.3, 128.8, 130.8, 132.3, 133.7, 139.0, 140.6, 153.4, and 177.2.
  • Wawzonek , S. and Hansen , G. R. 1975 . J. Org. Chem. , 40 : 2974 13C-NMR citation for methylene carbons in isomeric indeno[1,2-c]iscoumarin: (CDCl3), δ 41.0 ppm (CH2). See
  • Chemicals were purchased from Aldrich Chemical Co. The methyl esters for 6–8 were routinely prepared from either 5-chloro-, 5-bromo-, or 5-iodo-, salicylic acids, excess methanol and sulfuric acid. For example, methyl 5-bromosalicylate was prepared by treating 5-bromosalicylic acid (25 g) with 300 – 350 mL of methanol, 5 mL of conc. sulfuric acid, and heating the solution under reflux with stirring overnight (12 – 16 hr.). Speedy purification could be accomplished by reduction in volume (ca., 25 – 50 mL), followed by a single recrystallization of the solid product from methanol.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.